Help Sitemap Home Skip Navigation Contact Us Disability Statement

Sponsored by Oldrids
Sponsored by
Strait Bargate, Boston, Lincolnshire. Tel: 01205361251

Premium Article !

Your account has been frozen. For your available options click the below button.

Options

Premium Article !

To read this article in full you must have registered and have a Premium Content Subscription with the Press Association site.

Subscribe

Registered Article !

To read this article in full you must be registered with the site.

Whale slams 'barbaric' drugs ruling



View Video
Download Video

Video

Click on thumbnail to view image
Click on thumbnail to view image
Click on thumbnail to view image
Click on thumbnail to view image
Click on thumbnail to view image

Broadcaster James Whale has accused a health watchdog of being "barbaric" in denying kidney cancer patients access to four drugs.
The star, who was diagnosed with the disease in 2000 and set up a charity to raise awareness, said the National Institute for Health and Clinical Excellence (Nice) was a "very badly named organisation".

He slammed Nice's decision - which is subject to appeal - to deny patients access to Sutent (sunitinib), Avastin (bevacizumab), Nexavar (sorafenib) and Torisel (temsirolimus) on the NHS.

Mr Whale was 49 when he was diagnosed with cancer in 2000 after detecting blood in his urine.

"I had a very large tumour on my left kidney and had the kidney removed," he said.

"It's quite a shock to be diagnosed with cancer at any age. At that time there were no drugs available. Drugs, chemotherapy and radiotherapy don't work very well on internal organs.

"I was told by my specialist 'If you want, you can have treatment but the possibility is that it might do you more harm than good'. But the new drugs are very important in treating this particular cancer.

"I can only assume that the members of Nice - a very badly named organisation - have never been in this situation.

"Monetary considerations don't come into it. I think it's barbaric and it's politically motivated, in my view."

He questioned the point of charities raising money for research into new drugs, only for the drugs to then not be prescribed. "What's the point?" he said. He continued: "More people die from kidney cancer every year than die on the roads. If we could get a fraction of the money they spend on trying to stop road deaths each year then we could really do something."



Copyright (c) Press Association Ltd. 2008, All Rights Reserved.

The full article contains 310 words and appears in Press Association newspaper.
Page 1 of 1

  • Last Updated: 07 August 2008 11:39 AM
  • Source: Press Association
  • Location: The Press Association Newsdesk
 
 
  

 
 


Sister Newspapers:
Press Complaints Commission

This website and its associated newspaper adheres to the Press Complaints Commission’s Code of Practice. If you have a complaint about editorial content which relates to inaccuracy or intrusion, then contact the Editor by clicking here.

If you remain dissatisfied with the response provided then you can contact the PCC by clicking here.